WELLS FARGO & COMPANY/MN
Position in MLYS — Mineralys Therapeutics, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in MLYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,782,215
+$1,075,684 QoQ
Shares Held
66,057
+153.3% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#98
of 224 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,774,319 across 417 Biotechnology names. MLYS ranks #108 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in MLYS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,782,215 | 66,057 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $706,531 | 26,081 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $2,059,674 | 56,756 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,139,646 | 30,054 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $429,670 | 31,757 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $426,902 | 26,883 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $291,918 | 23,714 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $241,133 | 19,912 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $230,384 | 19,691 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $186,200 | 14,423 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $68,954 | 8,018 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $46,931 | 4,935 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $107,806 | 6,323 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $36,581 | 2,336 | Shares | Defined | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||